ProfileGDS4718 / 243045_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 64% 71% 70% 67% 57% 66% 66% 69% 69% 65% 64% 65% 60% 61% 66% 65% 65% 64% 66% 69% 65% 62% 62% 64% 62% 66% 59% 62% 68% 65% 66% 70% 68% 63% 65% 64% 71% 70% 69% 65% 68% 64% 62% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5238566
GSM549102patient 115, normal, homogenized [OPG study]6.4242664
GSM549104patient 119, normal, homogenized [OPG study]7.0272471
GSM549108patient 138, normal, homogenized [OPG study]6.8418570
GSM549119patient 077, normal, homogenized [OPG study]6.6435567
GSM549133patient 032, cancer, homogenized [OPG study]5.8942557
GSM549139patient 042, cancer, homogenized [OPG study]6.5502966
GSM549099patient 107, normal, homogenized [OPG study]6.5276666
GSM549109patient 139, normal, homogenized [OPG study]6.7997369
GSM549110patient 046, normal, homogenized [OPG study]6.758369
GSM549114patient 063, normal, homogenized [OPG study]6.4557165
GSM549122patient 082, normal, homogenized [OPG study]6.4213664
GSM549134patient 033, cancer, homogenized [OPG study]6.4597265
GSM549136patient 036, cancer, homogenized [OPG study]6.1152360
GSM549140patient 044, cancer, homogenized [OPG study]6.1633261
GSM549111patient 047, normal, homogenized [OPG study]6.5597166
GSM549113patient 057, normal, homogenized [OPG study]6.4549565
GSM549132patient 031, cancer, homogenized [OPG study]6.4571465
GSM549137patient 038, cancer, homogenized [OPG study]6.4039764
GSM549142patient 047, cancer, homogenized [OPG study]6.5813266
GSM549100patient 110, normal, homogenized [OPG study]6.7169169
GSM549107patient 135, normal, homogenized [OPG study]6.4798665
GSM549115patient 068, normal, homogenized [OPG study]6.2380462
GSM549116patient 072, normal, homogenized [OPG study]6.2964862
GSM549120patient 078, normal, homogenized [OPG study]6.4421464
GSM549131patient 030, cancer, homogenized [OPG study]6.2909662
GSM549118patient 074, normal, homogenized [OPG study]6.5797666
GSM549129patient 027, cancer, homogenized [OPG study]6.0717459
GSM549123patient 088, normal, homogenized [OPG study]6.2749562
GSM549124patient 006, cancer, homogenized [OPG study]6.662968
GSM549126patient 015, cancer, homogenized [OPG study]6.4906265
GSM549128patient 025, cancer, homogenized [OPG study]6.6470666
GSM549103patient 117, normal, homogenized [OPG study]6.8112270
GSM549117patient 073, normal, homogenized [OPG study]6.6903268
GSM549138patient 041, cancer, homogenized [OPG study]6.3694563
GSM549141patient 045, cancer, homogenized [OPG study]6.4813965
GSM549130patient 028, cancer, homogenized [OPG study]6.3728464
GSM549101patient 111, normal, homogenized [OPG study]6.985471
GSM549105patient 128, normal, homogenized [OPG study]6.8295970
GSM549106patient 134, normal, homogenized [OPG study]6.824569
GSM549112patient 048, normal, homogenized [OPG study]6.4652565
GSM549125patient 011, cancer, homogenized [OPG study]6.6644768
GSM549127patient 024, cancer, homogenized [OPG study]6.4601264
GSM549135patient 035, cancer, homogenized [OPG study]6.2377762